Market Closed

EWTX
Edgewise Therapeutics
$ 45.93
0.24%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago

Edgewise Therapeutics News

Latest Edgewise Therapeutics Stock News & EWTX Headlines

Edgewise Therapeutics to Participate in Upcoming Investor Conferences
7 days ago | prnewswire.com
Edgewise Therapeutics Reports Third Quarter 2026 Financial Results
11 days ago | prnewswire.com
Edgewise Therapeutics Doses First Patient in Phase 2 EQUINOX-HFpEF Trial of EDG-15400
a month ago | prnewswire.com
Edgewise Therapeutics, Inc. (EWTX) Discusses Differentiated Mechanism of Action of Cardiac Sarcomere Modulator EDG-7500 Transcript
2 months ago | seekingalpha.com
Edgewise Therapeutics Unveils the Differentiated Mechanism of Action (MoA) of its Cardiac Sarcomere Modulator EDG-7500
2 months ago | prnewswire.com
91,638 Shares in Edgewise Therapeutics, Inc. $EWTX Acquired by Hsbc Holdings PLC
2 months ago | defenseworld.net
Edgewise Therapeutics Announces Upcoming Late-Breaking Science Presentation at the European Society of Cardiology (ESC) Congress 2026
3 months ago | prnewswire.com
Edgewise Therapeutics: The Servier Deal Creates A Self-Funded Cardiovascular Platform
3 months ago | seekingalpha.com
Edgewise Therapeutics Reports Second Quarter 2026 Financial Results
3 months ago | prnewswire.com
Servier finalise l'acquisition de l'activité dystrophie musculaire d'Edgewise Therapeutics
4 months ago | prnewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

EWTX
Edgewise Therapeutics
$ 45.93
0.24%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago